Insights through AM1 calculations into the structural requirementof 3,4,6-substituted-2-quinolone analogs towards FMSk inaseinhibitory activity

European Journal of Medicinal Chemistry

Volumn 45, Issue 8, 2010, Pages 3472-3479

  Gupta, Arun Kumar ^a   Sabarwal, Neetu ^a   Agrawal, Yogesh P ^a   Prachand, Sumeet ^a   Jain, Sanjay ^a  

^a Smriti College of Pharmaceutical Education   (India)

Author keywords

3,4,6 substituted 2 quinolones; FMS kinaseinhibitor; QSAR

Indexed keywords

AMALGAM; COLONY STIMULATING FACTOR 1; QUINOLINE DERIVATIVE;

ARTICLE; DRUG POTENCY; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 77954309283     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.05.001     Document Type: Article

References (33)

1. C. J. Sherr,The fms oncogene. Biochim. Biophys. Acta 948 (1988) 225-243.
2. D. Metcalf,The Florey lecture: the colony-stimulating factors: discovery to clinical use. Philos Trans R Soc Lond B Biol Sci. 333 (1991) 147-173.
3. F. J. Pixley,E. R. Stanley,CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14 (2004) 628-638.
4. G. Yanni,A. Whelan,C. Feighery,B. Bresnihan,Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann. Rheum. Dis. 53 (1994) 39-44.
5. N. Yang,N. M. Isbel,D. J. Nikolic-Paterson,Y. Li,R. Ye,R. C. Atkins,H. Y. Lan,Local macrophage proliferation in human glomerulonephritis. Kidney Int. 54 (1998) 143-151.
6. H. M. Kluger,M. Dolled-Filhart,S. Rodov,B. M. Kacinski,R. L Camp,D. L. Rimm,Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis. Clin. Cancer Res. 10 (2004) 173-177.
7. E. Y. Lin,A. V. Nguyen,R. G. Russell,J. W. Pollard,Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193 (2001) 727-740.
8. L. D. Yee,L Liu,The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells. Anticancer Res. 20 (2000) 4379-4384.
9. J. G. Conway,B. McDonald,J. Parham,B. Keith,D. W. Rusnak,E. Shaw,M. Jansen,P. Lin,A. Payne,R. M. Crosby,J. H. Johnson,L. Frick,M.-HJ. Lin,S. Depee,S. Tadepalli,B. Votta,I. James,K. Fuller,T. J. Chambers,F. C. Kull,S. D. Chamberlain,J. T. Hutchins,Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 16078-16083.
10. E. H. D. Iman,M. Gallet,R. Mentaverri,N. Sevenet,M. Brazier,S. Kamel,Imatinib mesylate (Gleevec®) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity. Eur. J. Pharmacol. 551 (2006) 27-33.
11. I. A. Campbell,M. J. Rich,RJ. Bischof,J. A. Hamilton,The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukocyte Biol. 68 (2000) 144-150.
12. J. W. Pollard,E. R. Stanley,Pleiotropic roles for CSF-1 in development defined by the mouse mutation osteopetrotic. Adv. Devel. Biochem4 (1995) 153-193.
13. L Van Wesenbeeck,P. R. Odgren,C. A. MacKey,M. D'Angelo,F. F. Safadi,S. N. Popo,W. Van Hul,S. C. Marks Jr.,The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc. Nat. Acad. Sci. 99 (2002) 14303-14308.
14. D. Mandloi,S. Joshi,P. V. Khadikar,N. Khosla,QSAR study on the antibacterial activity of some sulfa drugs: building blockers of Mannich bases. Bioorg. Med. Chem. Lett. 15 (2005) 405-411.
15. C. R. Illig,M. J. Wall,J. Chen,S. Meegalla,S. K. Ballentine,K. J. Wilson,R. L DesJarlais,C. Schubert,M. A. Chaikin,C. Crysler,I. P. Petrounia,R. R. Donatelli,E. J. Yurkow,L. Boczon,M. Mazzulla,M. R. Player,RJ. Patch,C. L. Manthey,C. Molloy,B. Tomczuk,Synthesis and evaluation of novel 3,4,6-substituted-2-quinolones as FMS kinase inhibitors. Bioorg. Med. Chem. Lett. 18 (2008) 2097-2102. (Pubitemid 351391842)
16. CS ChemOffice,Version 11. 0,Cambridge Soft Corporation,Software Publishers Association,1730 M Street,Suite 700,Washington D. C. 20036,USA. Tel.: (202) 452-1600.
17. R. Todeschini,V. Consonni,DRAGON-Software for the Calculation of Molecular Descriptors,rel. 1. 12 for Windows (2001).
18. A. K. Gupta,B. M. Arockia,S. G. Kaskhedikar,VALSTAT: validation program for quantitative structure activity relationship studies. Indian J. Pharm. Sci. 66 (2004) 396-402.
19. M. J. S. Dewar,E. G. Zoebisch,E. F. Healey,J. J. P. Stewart,AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107 (1985) 3902-3909.
20. M. J. S. Dewar,C. H. Hwang,D. R. Kuhn,An AM1 study of the reactions of ozone with ethylene and 2-butene. J. Am. Chem. Soc. 113 (1991) 735-741.
21. P. U. Civcir,A theoretical study of tautomerism of 6-thiopurine in the gas and aqueous phases using AM1 and PM3. J. Mol. Struct: THEOCHEM 535 (2001) 121-129.
22. L. B. Kier,Molecular Orbital Theory in Drug Research,vol. 10,Academic Press,New York,1971.
23. K. J. Schaper,Free-Wilson-Type analysis of non-additive substituent effects on THPB dopamine receptor affinity using artificial neural networks. Quant. Structure Act. Relat. 18 (1999) 354-360.
24. S. Chatterjee,A. Hadi,B. Price,Regression Analysis by Examples,third ed. Wiley-VCH,New York,2000.
25. S. Shapiro,B. Guggenhei,Inhibition of oral bacteria by phenolic compounds. Part 1. QSAR analysis using molecular connectivity. Quant. Struct. Act. Relat 17 (1998) 327-337. (Pubitemid 28401255)
26. D. H. Cho,S. K. Lee,B. T. Kim,K. T. No,Quantitative structureeactivity relationship (QSAR) study of new fluorovinyloxyacetamides. Bull. Korean Chem. Soc. 22 (2001) 388-394.
27. M. C. Hemmer,V. Steinhauer,J. Gasteiger,Deriving the 3D structure of organic molecules from their infrared spectra. Vib. Spectrosc. 19 (1999) 151-164.
28. A. Fedorowicz,L. Zheng,H. Singh,E. Demchuk,QSAR study of skin sensiti-zation using local lymph node assay data. Int. J. Mol. Sci. 5 (2004) 56-66.
29. M. C. Hemmer,J. Gasteiger,Prediction of three-dimensional molecular structures using information from infrared spectra. Anal. Chim. Acta 420 (2000) 145-154.
30. J. Gasteiger,J. Sadowski,J. Schuur,P. Selzer,L. Steinhauer,V. Steinhauer,Chemical information in 3D space. J. Chem. Inf. Comput. Sci. 36 (1996) 1030-1037.
31. J. H. Schuur,P. Selzer,J. Gasteiger,The coding of the three-dimensional structure of molecules by molecular transforms and its application to structureespectra correlations and studies of biological activity. J. Chem. Inf. Comput. Sci. 36 (1996) 334-344.
32. J. Schuur,J. Gasteiger,Infrared spectra simulation of substituted benzene derivatives on the basis of a novel 3D structure representation. J. Anal. Chem. 69 (1997) 2398-2405.
33. R. Todeschini,V. Consonni,Handbook of Molecular Descriptors,vol. 11,Wiley-VCH,Weinheim,2000.